Biomarkers such as brain natriuretic peptide (BNP) are useful in monitoring chronic PAH [68], in risk-stratifying acute pulmonary embolism (see later) [69-71], and in identifying ARDS-related pulmonary vascular dysfunction [72], although their role is less clear in other ICU settings. Here, NPPB is linked to pulmonary arterial hypertension.